Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Single-Payer Healthcare
  • Federal Workers’ Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

WHAT'S NEW

  • Single-Payer Healthcare
  • Federal Workers' Medical Records
  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, May 25 2016

Full Issue

Anthem CEO: Despite 'Dynamic Tension' With Cigna, $48M Merger Deal On Track

CEO Joseph R. Swedish said the two insurers have resolved differences and are moving forward to receive regulatory approval. Still, investors are definitely watching.

The Wall Street Journal: Anthem CEO Says Cigna Deal Moving Forward

Anthem Inc. Chief Executive Joseph R. Swedish acknowledged “dynamic tension” with Cigna Corp. over their $48 billion pending merger, but said the health insurers had resolved differences and are on track to receive regulatory approval. The Wall Street Journal had reported that Anthem and Cigna were privately sparring on several fronts as they work toward antitrust clearance, citing letters their executives exchanged as recently as this month. Speaking at an investor conference in New York, Mr. Swedish called the disputes “old news.” He said the companies are working well together and have “virtually met all the deadlines up to this point” in the antitrust review by the Justice Department. (Hoffman and Wilde Mathews, 5/24)

The Wall Street Journal: Anthem And Cigna: What Worried Investors Have To Hear

Companies tend to break a few eggs when making a deal omelet, so investors probably shouldn’t fret too much about squabbling between Anthem and Cigna. It is the regulatory cook in the kitchen that is the bigger issue. Anthem and Cigna have bickered about a number of issues since agreeing to a deal last summer, raising fears the acquisition won’t close, The Wall Street Journal reported Monday. Anthem told investors Tuesday that isn’t likely to scuttle the deal, which it still expects will close sometime this year. (5/24)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF